WebApr 12, 2024 · About Hikma Pharmaceuticals (OTCMKTS:HKMPY) Stock Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. WebPrice To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Hikma Pharmaceuticals (HKMPF) ... Hikma Pharmaceuticals price target raised to 2,100 GBp from ...
Did you know?
WebApr 12, 2024 · Hikma Pharmaceuticals' mailing address is 1 NEW BURLINGTON PLACE, LONDON X0, W1S 2HR. The official website for the company is www.hikma.com. The company can be reached via phone at 442073992760, via email at [email protected], or via fax at 44-20-7399-2761. This page (OTCMKTS:HKMPF) was last updated on … WebHIKMA PHARMACEUTICALS PLC HIK Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals London Stock Exchange uses cookies to improve its website.
WebApr 12, 2024 · As of last trade, Hikma Pharmaceuticals PLC (HIK:LSE) traded at 1,650.00, 40.49% above the 52 week low of 1,174.50 set on Oct 24, 2024. 52-week range Today 1,174.50 Oct 24 2024 2,137.00 Mar 25... WebApr 13, 2024 · Hikma Pharmaceuticals Stock Up 1.6 % Shares of HIK opened at GBX 1,804.50 ($22.35) on Wednesday. The firm has a market cap of £3.98 billion, a P/E ratio of 2,651.49, a P/E/G ratio of 2.38 and a ...
WebView Hikma Pharmaceuticals Plc HKMPF investment & stock information. Get the latest Hikma Pharmaceuticals Plc HKMPF detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. WebApr 12, 2024 · Hikma Pharmaceuticals Stock Performance. The company has a debt-to-equity ratio of 59.73, a quick ratio of 1.27 and a current ratio of 1.86. The stock has a market cap of £3.91 billion, a P/E ...
WebApr 12, 2024 · Hikma Pharmaceuticals PLC announces that Riad Mishlawi, President of the Group's Injectables business, has been appointed Chief Executive Officer (CEO), effective 1 September 2024. Thereafter, Said Darwazah will step down as acting CEO and return to his role as Executive Chairman. As CEO, Riad will bring his deep knowledge of Hikma and the ...
WebInformation and tools for shareholders including our latest dividend, payments, historical data and dividend calculator. We pay dividends twice yearly. Find out more about dividends. cabinets for travel trailersWebApr 12, 2024 · Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe. cabinets for tiny kitchensWebApr 11, 2024 · -- Hikma Pharmaceuticals on Wednesday said it appointed Riad Mishlawi as the group's new chief executive officer, with effect Sept. 1. Mishlawi currently serves as the president of Hikma's... April 12, 2024 ... London Stock Exchange; Hikma Pharmaceuticals PLC. News. Summary HIK GB00B0LCW083. HIKMA PHARMACEUTICALS PLC (HIK) Add … clss eligibility criteriaWebApr 12, 2024 · HKMPF Stock Forecast, Price & News (Hikma Pharmaceuticals) Free Trial Research Tools My MarketBeat My Portfolio My Performance My Insights My Headlines My Calendar My Ratings My Insider Trades My Earnings My SEC Filings My Social My Newsletter My Portfolio Ideas My Account Calculators Dividend Calculator Dividend Yield … cabinets for the officeWebMar 30, 2024 · About Hikma Pharmaceuticals Plc. 1 NEW BURLINGTON PLACE, LONDON, W1S 2HR, United Kingdom +44 2073992760. Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a ... cabinets for toilet areaWebApr 6, 2024 · Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst institutional investors who own 51% Simply Wall St Published April 06, 2024 Source: Shutterstock Key Insights Given the large stake in the stock by institutions, Hikma Pharmaceuticals' stock price might be vulnerable to their trading decisions clss fail colorWebInvestments 21 Share Price $21.00 (As of Friday Closing) General Information Description Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. cls serwis